Treatment for Teens With Alcohol Abuse and Depression

NCT02227589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2020-02-05

No results posted yet for this study

Summary

The investigators will recruit adolescents with alcohol or cannabis abuse and clinically significant depression. All participants will receive 12 sessions of an evidence-based treatment for alcohol abuse, Motivation Enhancement Therapy/Cognitive Behavior Therapy-12, over 12 to 14 weeks. Those who are still depressed after 4 weeks will be randomized to receive treatment augmentation with either an integrated cognitive behavior therapy for depression, delivered by their study therapist, or depression treatment-as-usual in the community. The study hypothesis is that integrated depression treatment will surpass community treatment-as-usual in efficacy.

Conditions

Interventions

BEHAVIORAL

MET/CBT-12

Two sessions of motivation enhancement therapy followed by 10 sessions of cognitive behavior therapy targeting alcohol or cannabis abuse. These 12 sessions will be delivered over 12 to 14 weeks.

BEHAVIORAL

CBT-D

CBT-D consists of seven weekly sessions of cognitive behavior therapy targeting depression.

OTHER

D-TAU

D-TAU is treatment as usual in the community, targeting depression. It may consist of medication and/or behavioral intervention.

Sponsors & Collaborators

  • UConn Health

    collaborator OTHER
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • Duke University

    lead OTHER

Principal Investigators

  • John F Curry, PhD · Duke University

  • Yifrah Kaminer, M.D. · UConn Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
263 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-16
Primary Completion
2020-01-03
Completion
2020-01-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227589 on ClinicalTrials.gov